NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/rocket-pharmaceuti ...

NEW YORK, July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/rocket-pharmaceuticals-i ...

Group 1 - The recent learning session by Shanghai State-owned Assets Supervision and Administration Commission focused on cryptocurrencies and stablecoins, indicating a shift in the industry towards "cross-border clearing + asset tokenization" as Chinese securities firms upgrade their virtual currency trading licenses [1] - The brokerage sector is experiencing a bullish sentiment due to increased trading volumes, with daily average stock trading reaching 1.6 trillion yuan, a nearly 60% year-on-year increase, and margin financing remaining high at 1.8 trillion yuan, up nearly 20% year-on-year [2] - The implementation of reforms in the Sci-Tech Innovation Board and the relaxation of IPO regulations are expected to improve the investment banking business for brokerages, with a significant increase in IPO projects being processed [2] Group 2 - The industry has seen multiple significant merger and acquisition events in 2023, indicating a sustained interest in M&A themes [3] - The China Securities Regulatory Commission has issued a plan to promote the high-quality development of public funds, which may lead fund managers to increase allocations to currently underweighted sectors, including non-bank financials [3] - Historical data suggests that during bullish market expectations, the brokerage index's price-to-book (PB) ratio can quickly recover to above 2 times, with the current PB ratio at 1.47, indicating substantial potential for growth in the brokerage sector [4]

Market Performance - The three major U.S. indices closed higher, with the Dow Jones up by 192.34 points (0.43%) at 44,650.64 points, the Nasdaq up by 19.33 points (0.09%) at 20,630.66 points, and the S&P 500 up by 17.20 points (0.27%) at 6,280.46 points, with both the Nasdaq and S&P 500 reaching new all-time highs [1] - In the European market, the DAX30 index fell by 56.00 points (0.23%) to 24,465.93 points, while the FTSE 100 index rose by 110.69 points (1.25%) to 8,977.71 points [1][2] Company News - Nvidia's market capitalization closed at $4 trillion, with its stock price increasing nearly 1% [1] - Tesla's stock rose by 4.7% [1] - Nvidia's CEO Jensen Huang met with President Trump, who praised Nvidia's stock performance, noting a 47% increase since the implementation of tariffs [7] - Levi's raised its revenue guidance, expecting sales growth to withstand the impact of tariffs, leading to a 9% increase in its stock price in after-hours trading [8] Commodity and Currency Updates - Gold prices increased by 0.4% to $3,325.35 per ounce [3] - Bitcoin reached a new all-time high, continuing its upward trend, while Ethereum surpassed $3,000 for the first time since early February [3] - The U.S. dollar index rose by 0.1% to 97.652, with various currency exchange rates showing fluctuations against the dollar [2] Federal Reserve Insights - Federal Reserve Governor Waller expressed support for a potential interest rate cut in July, citing that current policy rates are too high [4] - San Francisco Fed President Daly indicated the possibility of two rate cuts in 2025, noting that the impact of tariffs on prices may be weaker than expected [5] - Fed official Musalem mentioned that the effects of tariffs might not be fully realized until later this year or early next year [6]

Core Viewpoint - Rocket Pharmaceuticals, Inc. is facing a class action lawsuit due to allegations of providing misleading statements regarding the safety and clinical trial protocol of its RP-A501 treatment, which resulted in significant stock price decline after the FDA placed a clinical hold on the study following a Serious Adverse Event [3][4]. Summary by Sections Allegations - The complaint alleges that Rocket Pharmaceuticals made overwhelmingly positive statements to investors while concealing material adverse facts about RP-A501's safety and clinical trial protocol, including the risk of Serious Adverse Events (SAEs) and participant deaths [3]. - The company amended the trial protocol to introduce a new immunomodulatory agent without informing shareholders, leading to artificially inflated stock prices [3]. - Following the announcement of the FDA's clinical hold on May 27, 2025, due to a patient's death, Rocket's stock price plummeted from $6.27 to $2.33, a decline of approximately 37% in one trading day [3]. Class Action Details - The class period for the lawsuit is from February 27, 2025, to May 26, 2025, with a deadline for shareholders to register as lead plaintiffs by August 11, 2025 [4]. - Shareholders who register will receive updates on the case's status through portfolio monitoring software [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

金十数据7月11日讯，李维斯（Levi Strauss）上调营收预期，这家501牛仔裤制造商预计销售增长将顶住 特朗普关税的影响。在纽约盘后交易中，该公司股价一度上涨9%。该公司目前预计本财年的营收将增 长1%至2%，高于分析师的平均预期，也高于此前销售将下降1%至2%的预期。这一结果表明，该公司 拓展新产品和新品类的努力正在取得成效。 牛仔裤制造商李维斯上调营收指引，股价盘后大涨9% ...

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rocket Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conti ...

NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT).Shareholders who purchased shares of RCKT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/rocket-pharmaceuticals-inc-loss-submission-form/?id=156038&from=4CLASS PERIO ...

沪深两市成交额为14941亿元人民币，相较上个交易日小幅缩量。 7月10日，港股三大股指涨跌互现，其中恒生中国央企指数上涨1.66%，涨幅相对居前。 | 证券名称 | 日涨跌幅 | | --- | --- | | 恒生中国央企指数 | 1.66% | | 恒生指数 | 0.57% | | 恒生科技指数 | -0.29% | | 数据来源： Wind，日期截至2025-07-10 | | 行业板块方面，房地产（3.19%）、石油石化（1.54%）、钢铁（1.45%）板块涨幅居前，汽车（-0.62%）、传媒（-0.54%）、国防军工（-0.41%）板块跌幅 居前。 二、今日热点追踪 一、市场行情回顾 7月10日，A股三大股指全线上涨，上证指数收涨0.48%，深证成指收涨0.47%，创业板指收涨0.22%，延续回暖态势。主流宽基指数中，中证A50上涨 0.64%，涨幅相对居前。全市场共有超2,900只股票上涨。 | 证券名称 | 日涨跌幅 | | --- | --- | | 中证A50 | 0.64% | | 中证500 | 0.50% | | 上证指数 | 0.48% | | 沪深300 | 0.47% | | ...

PALO ALTO, Calif.  , July 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing, and commercializing transformative therapeutics, announced today it will host an investor R&D Day webcast on Wednesday, July 16, 2025, from 4:00 pm ET to 5:30 pm ET.The virtual event will feature a comprehensive overview of Kodiak's three late-phase clinical assets (tarcocimab, KSI-501, KSI-101) through presentations from members of ...